There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 6000 | 11.8 |
| 1 | 6000 | 11.15 |
| 1 | 6000 | 10.85 |
| 1 | 6000 | 10.8 |
| 1 | 6000 | 10.75 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 60.2%, in the last year to ₹131.45 Cr. Its sector's average revenue growth for the last fiscal year was 12.14%.Annual Net Profit,rose 53.92% in the last year to ₹6.4 Cr. Its sector's average net profit growth for the last fiscal year was 1.91%.Price to Earning Ratio,is 11.6, lower than its sector PE ratio of 46.91.JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World.
To maintain its competitiveness and to further the cause of health care JFL has laid a strong RD foundation and a FDA approved state of the art manufacturing facility near Ahmedabad. It is a manufacturing company, so its sales strategy is to sell its products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. It does not sell it under any brand name and it use the same strategy for both domestic international market.
The intraday high for Jfl Life Sciences Limited on the NSE today (28 Jul 2026) was ₹11.90. This compares to the 52-week high of ₹15.13 recorded on 30 Jul 2025. Today's high was -21.35% below the 52-week high.
For Q4 FY26, Jfl Life Sciences Limited reported: Revenue (Net Sales): ₹630.55 Cr - Up 134.96% year-on-year from ₹268.36 Cr in Q3 FY26. Net Income (PAT): ₹16.60 Cr - Down -17.74% year-on-year from ₹20.18 Cr in Q3 FY26.
The intraday low for Jfl Life Sciences Limited on the NSE today was ₹10.85. The stock's 52-week low stands at ₹8.55, recorded on 30 Mar 2026. Today's low is 26.90% above the 52-week low, indicating the stock is trading well above its yearly lows.
As of 28 Jul 2026, the share price of Jfl Life Sciences Limited is ₹11.80 on the NSE and ₹N/A on the BSE. The stock opened at ₹11.70, touched a high of ₹11.90 and a low of ₹10.85 during today's session.
Over the last 6 months, Jfl Life Sciences Limited has given a return of 12.78%. The stock was priced at ₹9.98 on 29 Jan 2026 and has Rise to ₹11.80 as of 28 Jul 2026, a change of ₹1.83 per share.
Jfl Life Sciences Limited has delivered a return of 19.68% over the last 3 months. The stock was trading at ₹9.40 on 28 Apr 2026 and is currently at ₹11.80 as of 28 Jul 2026, reflecting a Gain of ₹2.40 per share over this period.
No,Jfl Life Sciences Limited has not declared any dividend over the past 5 years. The company paid a total dividend of 0.25 per share between FY2022 and FY2026, with the most recent dividend of ₹0.25 per share for Aug 24, with an ex-dividend date of 13 Sep 2024. At the current market price of ₹11.80, the trailing dividend yield of Jfl Life Sciences Limited stands at 0.25%.
Jfl Life Sciences Limited has delivered a N/A% absolute return over the past 5 years, equivalent to a CAGR of N/A% per annum. The stock was priced at ₹N/A in Jul 2021 and has fallen to ₹11.80 as of 28 Jul 2026. An investment of ₹1,00,000 in Jfl Life Sciences Limited five years ago would be worth ₹N/A today.
The all-time high (ATH) for Jfl Life Sciences Limited was ₹33.79, recorded on 22 Nov 2024. At the current price of ₹11.80, the stock is trading 65.08% below its all-time high. The all-time low recorded was ₹8.55 on 30 Mar 2026.
Jfl Life Sciences Limited has delivered -25.88% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹15.13 on 30 Jul 2025 and a 52-week low of ₹8.55 on 30 Mar 2026. It is currently trading at ₹11.80 as of 28 Jul 2026.
